FDA Clearance Tracker · P930038-S067
ANGIO-SEAL VASCULAR CLOSURE DEVICE
Last checked: Nov 20, 2026Latest source record: Apr 15, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Apr 15, 2013
Approved
Time to decision
650 days
Received Jul 5, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P930038-S067
- Device name
- ANGIO-SEAL VASCULAR CLOSURE DEVICE
- Applicant
- Terumo Medical Corporation
- Applicant location
- Elkton, MD
- Received
- Jul 5, 2011
- Decided
- Apr 15, 2013
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P930038
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT ST. JUDE MEDICAL, INC., IN MINNETONKA, MINNESOTA.
Source documents
Other decisions for Terumo Medical Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MISAGO(TM) RX Self-expanding Peripheral StentPMA supplement
P140002-S032 · Decided Jul 16, 2026 · 199 days after receipt · Panel Track
Device type: STENT, ILIAC (NIO) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.